Literature DB >> 199377

New micromethod for measuring cholesterol in plasma lipoprotein fractions.

T J Bronzert, H B Brewer.   

Abstract

A method is described for the reliable, fast, and relatively inexpensive fractionation of plasma lipoproteins and quantitation of their cholesterol content. This procedure requires 350 microliter of plasma and can be completed within 3 h. Plasma lipoproteins (175 microliter of plasma) were prestained with Fat Red 7B and centrifuged (Beckman Airfuge) at plasma density (d = 1.006 kg/liter) and at a solvent density of 1.060 kg/liter, adjusted by adding solid KBr. Prestained centrifuged samples demonstrated the characteristic elevation of chylomicrons in phenotypes I and V, low-density lipoproteins of phenotype II, very-low-density lipoproteins in phenotype IV and V, and continuum of pink color throughout the centrifuge tube, diagnostic of the floating beta lipoprotein of type III. Centrifuged samples were separated into top and bottom fractions by aspiration. Cholesterol was quantitated with an enzymic oxygen-electrode analyzer (Beckman Cholesterol Analyzer). Correlation coefficients between cholesterol values for plasma from normal hyperlipidemic individuals obtained with the Beckman Analyzer vs. the Technicon AutoAnalyzer II and SMAC systems were 0.977 and 0.973, respectively.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199377

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  27 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  The aryl hydrocarbon receptor is activated by modified low-density lipoprotein.

Authors:  Brian J McMillan; Christopher A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

3.  The hypocholesterolemic effect of guar gum depends on dietary sucrose--studies in minipigs.

Authors:  F Ahrens; M Pfeuffer; H Hagemeister; C A Barth
Journal:  Z Ernahrungswiss       Date:  1991-06

4.  Pharmacokinetic properties of YM17E, an inhibitor of acyl coenzyme A: cholesterol acyl transferase, and serum cholesterol levels in healthy volunteers.

Authors:  T Uchida; T Usui; T Watanabe; S Higuchi; M Nakata; K Maezawa; Y Kikawa; M Tsunoo; N Nakaya; Y Goto
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

5.  Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity.

Authors:  D J McNamara; R Kolb; T S Parker; H Batwin; P Samuel; C D Brown; E H Ahrens
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  Evaluation of the polychlorobiphenyl Aroclor 1254 in an animal model of atherosclerosis.

Authors:  J W Carter; S I Koo
Journal:  Arch Environ Contam Toxicol       Date:  1988-05       Impact factor: 2.804

7.  Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.

Authors:  T S Parker; D J McNamara; C Brown; O Garrigan; R Kolb; H Batwin; E H Ahrens
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizes.

Authors:  D J McNamara; E H Ahrens; R Kolb; C D Brown; T S Parker; N O Davidson; P Samuel; R M McVie
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Influence of dietary casein and soy protein isolate on intestinal cholesterol and bile acid concentration.

Authors:  K E Scholz; E Kinder; H Hagemeister; C A Barth
Journal:  Z Ernahrungswiss       Date:  1985-09

10.  Quantitation of baboon lipoproteins by high performance gel exclusion chromatography.

Authors:  M C Williams; R S Kushwaha; H C McGill
Journal:  Lipids       Date:  1987-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.